Jason Hou, MD, on Positioning Anticytokines and Anti-Integrins in IBD Management
09/25/2020
Jason Hou, MD, gives a recap of his talk on using anticytokine and anti-integrin therapeutics in treating patients with inflammatory bowel disease, which he presented at the virtual Advances in Inflammatory Bowel Disease regional meeting September 26.
Additional Resources:
For more information about AIBD 2020 and to register for the AIBD Annual Meeting in December, visit https://www.advancesinibd.com
Jason Hou, MD, is an associate professor of medicine and gastroenterologist from Baylor College of Medicine in Houston, Texas.
